MoneyWorks4Me

Sanjivani Paranteral board to approve un-audited financial results

17 Jul 2021 Evaluate

Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Sanjivani Paranteral has informed that the meeting of the Board of Directors of the Company is scheduled on 26/07/2021, to consider and approve the Un-Audited Financial Results of the Company for the quarter and financial year ended June 30, 2021; and any other matter with the permission of the chair.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..